The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Also known as: C-Reactive Protein, CReactive Protein CRP, CRP
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: Glucose Tolerance Test 2 Specimens 75g
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Insulin Response to Glucose 2 Specimens
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
The DH-4. Diabetes Health panel contains 8 tests with 70 biomarkers.
Brief Description: The DH-4 Diabetes Health panel is a comprehensive suite of tests tailored for individuals with diabetes, particularly those with complex management needs or those at high risk for complications. This panel includes C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), 2 Specimen Glucose Tolerance Test, Hemoglobin A1c, Insulin, 2 Specimen Insulin Response to Glucose, Lipid Panel, and Random Urine Microalbumin with Creatinine. It is designed to provide a thorough assessment of diabetes control, cardiovascular risk, insulin function, kidney health, and overall metabolic status.
Collection Method: Blood Draw and Urine Collection
Specimen Type: Whole Blood, Serum, and Urine
Test Preparation: High carbohydrate diet for 3 days before test. Overnight fasting is required.
The DH-4 panel may be ordered for individuals with diabetes who are not achieving their glycemic targets with current management plans, those experiencing symptoms of diabetes complications, or individuals with type 1 diabetes who require detailed monitoring. It's also valuable for patients with type 2 diabetes who have multiple cardiovascular risk factors or signs of insulin resistance. This panel aids in fine-tuning treatment strategies, identifying early signs of complications, and making more informed decisions about patient care.
C-Reactive Protein (CRP): Measures inflammation levels in the body, which can indicate an increased risk of cardiovascular disease, especially important in the context of diabetes.
CBC with Differential and Platelets: Provides a detailed look at blood cells, helping to identify conditions like anemia or infections that could complicate diabetes management or indicate underlying conditions.
Comprehensive Metabolic Panel (CMP): Evaluates glucose levels, liver and kidney function, electrolyte and fluid balance, and more, giving a snapshot of the metabolic health and how it's affected by diabetes.
2 Specimen Glucose Tolerance Test: Assesses how well the body processes glucose over a period, using two samples taken at different times. This test can diagnose prediabetes, gestational diabetes, or type 2 diabetes.
Hemoglobin A1c: Provides an average of blood glucose levels over the last two to three months, offering insight into the long-term control of diabetes.
2 Specimen Insulin Response to Glucose: Similar to the glucose tolerance test but focuses on how insulin levels respond to glucose intake, providing insight into insulin sensitivity and pancreatic function.
Lipid Panel: Checks the levels of various fats in the blood, including cholesterol and triglycerides, which are important for assessing cardiovascular risk in diabetic patients.
Random Urine Microalbumin with Creatinine: Screens for early kidney damage by detecting albumin in the urine, a common complication of diabetes.
The DH-4 panel is instrumental in managing and monitoring diabetes and its many facets. It can detect insulin resistance, evaluate the risk for cardiovascular diseases (through CRP and lipid levels), monitor kidney health (via microalbuminuria), and provide a detailed view of glucose metabolism and insulin functionality with the glucose tolerance and insulin response tests. These comprehensive insights are crucial for preventing and managing diabetes complications like nephropathy, retinopathy, and neuropathy.
Healthcare professionals use the DH-4 panel results to develop or adjust comprehensive diabetes management plans. Elevated CRP levels might lead to strategies aimed at reducing cardiovascular risk, while the glucose tolerance and insulin response tests can help in tailoring medication regimens or dietary recommendations. Abnormal kidney tests prompt early interventions to protect renal health, and the overall panel results can guide lifestyle modifications, medication adjustments, and other therapeutic measures.
The DH-4 Diabetes Health panel stands as a pivotal tool in the nuanced management of diabetes, offering a multifaceted view of a patient's health and the interplay between diabetes and various bodily systems. By providing detailed insights across a wide spectrum of health indicators, this panel enables healthcare professionals to craft highly personalized and effective management plans, ensuring the best possible outcomes for patients navigating the complexities of diabetes.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.